Methylprednisolone succinate

• UNSPSC Description:

  Methylprednisolone succinate is a synthetic glucocorticoid and widely used as an anti-inflammatory agent.

• Target Antigen:

  Bacterial; Glucocorticoid Receptor

• Type:

  Reference compound

• Related Pathways:

  Anti-infection;Immunology/Inflammation;Vitamin D Related/Nuclear Receptor

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer; Inflammation/Immunology; Endocrinology

• Assay Protocol:

  https://www.medchemexpress.com/Methylprednisolone_succinate.html

• Purity:

  99.55

• Solubility:

  DMSO : ≥ 100 mg/mL

• Smiles:

  C[C@@]12[C@](C(COC(CCC(O)=O)=O)=O)(O)CC[C@@]1([H])[C@]3([H])C[C@H](C)C4=CC(C=C[C@]4(C)[C@@]3([H])[C@@H](O)C2)=O

• Molecular Weight:

  474.54

• References & Citations:

  [1]Marchant A, et al. Methylprednisolone differentially regulates IL-10 and tumour necrosis factor (TNF) productionduring murine endotoxaemia. Clin Exp Immunol. 1996 Oct;106(1):91-6.|[2]Diem R, et al. Methylprednisolone increases neuronal apoptosis during autoimmune CNS inflammation by inhibition of an endogenous neuroprotective pathway. J Neurosci. 2003 Aug 6;23(18):6993-7000.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  4°C (Powder, protect from light)

• Clinical Information:

  Launched

• CAS Number:

  2921-57-5